| Symbol |
Name |
Standardized Value |
|
NGF
|
nerve growth factor (beta polypeptide)
|
2.905
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
2.87
|
|
UPK3A
|
uroplakin 3A
|
2.843
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
2.827
|
|
TAC1
|
tachykinin, precursor 1
|
2.76
|
|
UPK1A
|
uroplakin 1A
|
2.673
|
|
IL6
|
interleukin 6
|
2.6
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
2.562
|
|
IL1B
|
interleukin 1, beta
|
2.502
|
|
TNF
|
tumor necrosis factor
|
2.486
|
|
UPK2
|
uroplakin 2
|
2.471
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
2.456
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
2.387
|
|
TLR4
|
toll-like receptor 4
|
2.332
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.316
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.308
|
|
ALB
|
albumin
|
2.288
|
|
UPK1B
|
uroplakin 1B
|
2.282
|
|
KRT20
|
keratin 20, type I
|
2.281
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
2.277
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
2.253
|
|
CD34
|
CD34 molecule
|
2.246
|
|
BDNF
|
brain-derived neurotrophic factor
|
2.222
|
|
TACR1
|
tachykinin receptor 1
|
2.215
|
|
CD4
|
CD4 molecule
|
2.212
|
|
IFNG
|
interferon, gamma
|
2.202
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
2.185
|
|
IL10
|
interleukin 10
|
2.162
|
|
KLK3
|
kallikrein-related peptidase 3
|
2.157
|
|
KNG1
|
kininogen 1
|
2.156
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
2.109
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
2.105
|
|
CD8A
|
CD8a molecule
|
2.101
|
|
IL2
|
interleukin 2
|
2.091
|
|
UMOD
|
uromodulin
|
2.074
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
2.048
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
2.04
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
2.037
|
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3
|
2.031
|
|
TP53
|
tumor protein p53
|
2.03
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.027
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.022
|
|
IL1A
|
interleukin 1, alpha
|
2.019
|
|
MPO
|
myeloperoxidase
|
2.012
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
2.008
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
1.989
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.985
|
|
KRT7
|
keratin 7, type II
|
1.971
|
|
IL4
|
interleukin 4
|
1.963
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
1.963
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.951
|
|
LCN2
|
lipocalin 2
|
1.936
|
|
IL17A
|
interleukin 17A
|
1.92
|
|
CRH
|
corticotropin releasing hormone
|
1.909
|
|
TJP1
|
tight junction protein 1
|
1.899
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.897
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.892
|
|
INS
|
insulin
|
1.884
|
|
EGF
|
epidermal growth factor
|
1.859
|
|
CD19
|
CD19 molecule
|
1.854
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
1.851
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
1.848
|
|
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2
|
1.846
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.842
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.841
|
|
STRADB
|
STE20-related kinase adaptor beta
|
1.841
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
1.821
|
|
TLR5
|
toll-like receptor 5
|
1.811
|
|
FZD8
|
frizzled class receptor 8
|
1.809
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.807
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
1.799
|
|
PXDNL
|
peroxidasin-like
|
1.799
|
|
PXDN
|
peroxidasin
|
1.797
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.792
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.789
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.788
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.787
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
1.787
|
|
IL5
|
interleukin 5
|
1.781
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.777
|
|
TLR2
|
toll-like receptor 2
|
1.773
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.77
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
1.767
|
|
IL18
|
interleukin 18
|
1.758
|
|
FN1
|
fibronectin 1
|
1.755
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
1.751
|
|
ACTB
|
actin, beta
|
1.746
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
1.745
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
1.744
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.743
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.737
|
|
NGFR
|
nerve growth factor receptor
|
1.737
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.736
|
|
PAPOLG
|
poly(A) polymerase gamma
|
1.722
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.719
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.719
|
|
ARTN
|
artemin
|
1.717
|
|
ADRB3
|
adrenoceptor beta 3
|
1.713
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.712
|
|
ANK1
|
ankyrin 1, erythrocytic
|
1.708
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
1.695
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
1.695
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
1.695
|
|
HRH1
|
histamine receptor H1
|
1.694
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.676
|
|
EQTN
|
equatorin, sperm acrosome associated
|
1.67
|
|
IL13
|
interleukin 13
|
1.666
|
|
VIP
|
vasoactive intestinal peptide
|
1.666
|
|
HMOX1
|
heme oxygenase 1
|
1.663
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.66
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.656
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
1.656
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
1.655
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
1.654
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.652
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.652
|
|
GAL
|
galanin/GMAP prepropeptide
|
1.651
|
|
MMP9
|
matrix metallopeptidase 9
|
1.651
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
1.648
|
|
IFNA1
|
interferon, alpha 1
|
1.648
|
|
ACE
|
angiotensin I converting enzyme
|
1.631
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.627
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.624
|
|
JUN
|
jun proto-oncogene
|
1.621
|
|
KRT5
|
keratin 5, type II
|
1.621
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.615
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.612
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.612
|
|
LTF
|
lactotransferrin
|
1.61
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.609
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
1.606
|
|
GATA3
|
GATA binding protein 3
|
1.606
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.602
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
1.596
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.592
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
1.587
|
|
CD248
|
CD248 molecule, endosialin
|
1.583
|
|
POMC
|
proopiomelanocortin
|
1.582
|
|
OPRM1
|
opioid receptor, mu 1
|
1.582
|
|
EGFR
|
epidermal growth factor receptor
|
1.582
|
|
CMA1
|
chymase 1, mast cell
|
1.582
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
1.578
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.576
|
|
CD68
|
CD68 molecule
|
1.573
|
|
ESR1
|
estrogen receptor 1
|
1.566
|
|
CD274
|
CD274 molecule
|
1.564
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.561
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.561
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.56
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.559
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.558
|
|
FGF7
|
fibroblast growth factor 7
|
1.556
|
|
P3H4
|
prolyl 3-hydroxylase family member 4 (non-enzymatic)
|
1.555
|
|
VIM
|
vimentin
|
1.553
|
|
CDX2
|
caudal type homeobox 2
|
1.541
|
|
OCLN
|
occludin
|
1.54
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
1.537
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.537
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
1.536
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
1.531
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.526
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.522
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.52
|
|
GFRA3
|
GDNF family receptor alpha 3
|
1.52
|
|
BAX
|
BCL2-associated X protein
|
1.52
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.52
|
|
PRTN3
|
proteinase 3
|
1.518
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.509
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.509
|
|
AOAH
|
acyloxyacyl hydrolase (neutrophil)
|
1.504
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.504
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.502
|
|
IFNA2
|
interferon, alpha 2
|
1.5
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.498
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.497
|
|
TACR2
|
tachykinin receptor 2
|
1.495
|
|
UBAC1
|
UBA domain containing 1
|
1.493
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.491
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
1.491
|
|
IREB2
|
iron-responsive element binding protein 2
|
1.484
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
1.479
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.476
|
|
KITLG
|
KIT ligand
|
1.47
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
1.469
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.466
|
|
KRT13
|
keratin 13, type I
|
1.466
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.465
|
|
PENK
|
proenkephalin
|
1.465
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.456
|
|
P2RY4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4
|
1.451
|
|
SDC1
|
syndecan 1
|
1.449
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.447
|
|
CD86
|
CD86 molecule
|
1.447
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
1.445
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.444
|
|
ENG
|
endoglin
|
1.442
|
|
MME
|
membrane metallo-endopeptidase
|
1.437
|
|
KRT14
|
keratin 14, type I
|
1.436
|
|
TERT
|
telomerase reverse transcriptase
|
1.436
|
|
OXA1L
|
oxidase (cytochrome c) assembly 1-like
|
1.436
|
|
F2
|
coagulation factor II (thrombin)
|
1.436
|
|
CD52
|
CD52 molecule
|
1.433
|
|
C3
|
complement component 3
|
1.433
|
|
AVP
|
arginine vasopressin
|
1.427
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
1.425
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
1.425
|
|
PCDH8
|
protocadherin 8
|
1.425
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.421
|
|
DEFB1
|
defensin, beta 1
|
1.42
|
|
DEFB4A
|
defensin, beta 4A
|
1.419
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.417
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.416
|
|
OGA
|
O-GlcNAcase
|
1.412
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
1.412
|
|
CD80
|
CD80 molecule
|
1.406
|
|
IFNA17
|
interferon, alpha 17
|
1.401
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.399
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
1.398
|
|
CYCS
|
cytochrome c, somatic
|
1.396
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
1.394
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
1.393
|
|
GPX5
|
glutathione peroxidase 5
|
1.393
|
|
CCND1
|
cyclin D1
|
1.39
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.385
|
|
ELANE
|
elastase, neutrophil expressed
|
1.383
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
1.382
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.382
|
|
PDCD1
|
programmed cell death 1
|
1.38
|
|
GPX7
|
glutathione peroxidase 7
|
1.379
|
|
GPX6
|
glutathione peroxidase 6
|
1.378
|
|
GPX2
|
glutathione peroxidase 2
|
1.375
|
|
GPX3
|
glutathione peroxidase 3
|
1.372
|
|
PDYN
|
prodynorphin
|
1.371
|
|
GPR18
|
G protein-coupled receptor 18
|
1.371
|
|
MDH2
|
malate dehydrogenase 2, NAD (mitochondrial)
|
1.37
|
|
B2M
|
beta-2-microglobulin
|
1.369
|
|
MUC1
|
mucin 1, cell surface associated
|
1.366
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.364
|
|
NTF3
|
neurotrophin 3
|
1.364
|
|
TLR7
|
toll-like receptor 7
|
1.363
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
1.362
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
1.361
|
|
NTF4
|
neurotrophin 4
|
1.361
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.361
|
|
MMP2
|
matrix metallopeptidase 2
|
1.361
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.36
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
1.355
|
|
IL7
|
interleukin 7
|
1.354
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.354
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
1.353
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.353
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.351
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
1.347
|
|
CLDN2
|
claudin 2
|
1.347
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
1.346
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.344
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.34
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
1.339
|
|
GSTM1
|
glutathione S-transferase mu 1
|
1.337
|
|
FOXP3
|
forkhead box P3
|
1.337
|
|
REN
|
renin
|
1.335
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
1.334
|
|
HMGB1
|
high mobility group box 1
|
1.334
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.333
|
|
THY1
|
Thy-1 cell surface antigen
|
1.333
|
|
DHFR2
|
dihydrofolate reductase 2
|
1.331
|
|
EPRS1
|
glutamyl-prolyl-tRNA synthetase 1
|
1.331
|
|
AIF1
|
allograft inflammatory factor 1
|
1.326
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
1.321
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.319
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.318
|
|
IL15
|
interleukin 15
|
1.317
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.316
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.315
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
1.315
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.314
|
|
IL3
|
interleukin 3
|
1.314
|
|
SHH
|
sonic hedgehog
|
1.313
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.312
|
|
CTH
|
cystathionine gamma-lyase
|
1.312
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
1.311
|
|
FGF10
|
fibroblast growth factor 10
|
1.31
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.31
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.309
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
1.306
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.304
|
|
TLR1
|
toll-like receptor 1
|
1.302
|
|
RAD51
|
RAD51 recombinase
|
1.302
|
|
IFNA6
|
interferon, alpha 6
|
1.302
|
|
IFNA5
|
interferon, alpha 5
|
1.301
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
1.299
|
|
IFNA4
|
interferon, alpha 4
|
1.297
|
|
IFNA16
|
interferon, alpha 16
|
1.296
|
|
UPK3B
|
uroplakin 3B
|
1.296
|
|
IFNA7
|
interferon, alpha 7
|
1.295
|
|
IFNA14
|
interferon, alpha 14
|
1.295
|
|
IFNA21
|
interferon, alpha 21
|
1.295
|
|
IFNA10
|
interferon, alpha 10
|
1.295
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.294
|
|
IFNA8
|
interferon, alpha 8
|
1.294
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
1.292
|
|
IFNA13
|
interferon, alpha 13
|
1.292
|
|
CD40LG
|
CD40 ligand
|
1.291
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
1.29
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.29
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.289
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.288
|
|
KDR
|
kinase insert domain receptor
|
1.288
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
1.287
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
1.286
|
|
GSR
|
glutathione reductase
|
1.285
|
|
PPAN-P2RY11
|
PPAN-P2RY11 readthrough
|
1.285
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.278
|
|
RNASE6
|
ribonuclease, RNase A family, k6
|
1.277
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.275
|
|
DHFR
|
dihydrofolate reductase
|
1.272
|
|
FGF4
|
fibroblast growth factor 4
|
1.272
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
1.27
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
1.268
|
|
TH
|
tyrosine hydroxylase
|
1.266
|
|
NCF1
|
neutrophil cytosolic factor 1
|
1.265
|
|
ZDHHC2
|
zinc finger, DHHC-type containing 2
|
1.265
|
|
JAK2
|
Janus kinase 2
|
1.265
|
|
DSG2
|
desmoglein 2
|
1.265
|
|
CD38
|
CD38 molecule
|
1.264
|
|
OR2L5
|
olfactory receptor, family 2, subfamily L, member 5
|
1.264
|
|
CD5
|
CD5 molecule
|
1.261
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.261
|
|
IRF3
|
interferon regulatory factor 3
|
1.26
|
|
CD28
|
CD28 molecule
|
1.259
|
|
KRT18
|
keratin 18, type I
|
1.257
|
|
IL9
|
interleukin 9
|
1.255
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
1.255
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
1.254
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
1.254
|
|
CCK
|
cholecystokinin
|
1.253
|
|
MGAM
|
maltase-glucoamylase
|
1.249
|
|
GSTP1
|
glutathione S-transferase pi 1
|
1.248
|
|
IL33
|
interleukin 33
|
1.248
|
|
FGF3
|
fibroblast growth factor 3
|
1.247
|
|
SST
|
somatostatin
|
1.246
|
|
TYMP
|
thymidine phosphorylase
|
1.245
|
|
PTX3
|
pentraxin 3, long
|
1.243
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
1.243
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.241
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
1.24
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.24
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.237
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.237
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.237
|
|
NOX1
|
NADPH oxidase 1
|
1.237
|
|
FGF9
|
fibroblast growth factor 9
|
1.236
|
|
ATM
|
ATM serine/threonine kinase
|
1.236
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
1.232
|
|
FGF6
|
fibroblast growth factor 6
|
1.231
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
1.231
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.23
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.23
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.23
|
|
HP
|
haptoglobin
|
1.23
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.228
|
|
IL11
|
interleukin 11
|
1.227
|
|
TLR9
|
toll-like receptor 9
|
1.226
|
|
FGF22
|
fibroblast growth factor 22
|
1.225
|
|
FGF16
|
fibroblast growth factor 16
|
1.224
|
|
TPMT
|
thiopurine S-methyltransferase
|
1.223
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
1.221
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.22
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.219
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
1.218
|
|
FGF5
|
fibroblast growth factor 5
|
1.215
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
1.215
|
|
FGF18
|
fibroblast growth factor 18
|
1.215
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
1.214
|
|
ANXA5
|
annexin A5
|
1.214
|
|
AR
|
androgen receptor
|
1.213
|
|
FGF20
|
fibroblast growth factor 20
|
1.213
|
|
FGF17
|
fibroblast growth factor 17
|
1.211
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
1.211
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
1.21
|
|
CST3
|
cystatin C
|
1.209
|
|
CHAT
|
choline O-acetyltransferase
|
1.204
|
|
COMT
|
catechol-O-methyltransferase
|
1.204
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
1.203
|
|
TLR3
|
toll-like receptor 3
|
1.202
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
1.201
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.201
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.198
|
|
TAGLN3
|
transgelin 3
|
1.193
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.192
|
|
STX2
|
syntaxin 2
|
1.191
|
|
PLG
|
plasminogen
|
1.189
|
|
NRTN
|
neurturin
|
1.189
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.186
|
|
GCG
|
glucagon
|
1.186
|
|
RHOA
|
ras homolog family member A
|
1.183
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.181
|
|
EPO
|
erythropoietin
|
1.18
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
1.179
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.178
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
1.178
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.178
|
|
UCN
|
urocortin
|
1.17
|
|
JAK1
|
Janus kinase 1
|
1.163
|
|
HRH2
|
histamine receptor H2
|
1.163
|
|
PTEN
|
phosphatase and tensin homolog
|
1.16
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.16
|
|
CD33
|
CD33 molecule
|
1.16
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.159
|
|
HRH3
|
histamine receptor H3
|
1.157
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.157
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.156
|
|
PNOC
|
prepronociceptin
|
1.154
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.153
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.153
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.152
|
|
CALML4
|
calmodulin-like 4
|
1.151
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
1.15
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.149
|
|
NTS
|
neurotensin
|
1.149
|
|
CALML5
|
calmodulin-like 5
|
1.148
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
1.146
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
1.146
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.143
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
1.143
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
1.142
|
|
CALML6
|
calmodulin-like 6
|
1.141
|
|
TAGLN
|
transgelin
|
1.141
|
|
IL22
|
interleukin 22
|
1.14
|
|
SMAD2
|
SMAD family member 2
|
1.139
|
|
CALML3
|
calmodulin-like 3
|
1.139
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.136
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
1.136
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.134
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.133
|
|
SPP1
|
secreted phosphoprotein 1
|
1.133
|
|
TXN
|
thioredoxin
|
1.131
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.129
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
1.128
|
|
TAGLN2
|
transgelin 2
|
1.128
|
|
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9
|
1.127
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.127
|
|
LTA
|
lymphotoxin alpha
|
1.126
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.126
|
|
THBD
|
thrombomodulin
|
1.123
|
|
NPY
|
neuropeptide Y
|
1.123
|
|
SELL
|
selectin L
|
1.123
|
|
GAP43
|
growth associated protein 43
|
1.123
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
1.122
|
|
XDH
|
xanthine dehydrogenase
|
1.12
|
|
GFRA2
|
GDNF family receptor alpha 2
|
1.118
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.117
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
1.116
|
|
SELE
|
selectin E
|
1.115
|
|
CD63
|
CD63 molecule
|
1.115
|
|
CFH
|
complement factor H
|
1.115
|
|
FAAH
|
fatty acid amide hydrolase
|
1.113
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.112
|
|
TP63
|
tumor protein p63
|
1.112
|
|
TOP1
|
topoisomerase (DNA) I
|
1.112
|
|
PNLIP
|
pancreatic lipase
|
1.112
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
1.108
|
|
CD22
|
CD22 molecule
|
1.108
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
1.107
|
|
GLI3
|
GLI family zinc finger 3
|
1.107
|
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
1.106
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.104
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.103
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.102
|
|
ASIC5
|
acid sensing (proton gated) ion channel family member 5
|
1.102
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.102
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.101
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.101
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.101
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.097
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
1.095
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.094
|
|
HRH4
|
histamine receptor H4
|
1.093
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.092
|
|
ADORA2A
|
adenosine A2a receptor
|
1.091
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
1.091
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.09
|
|
GFAP
|
glial fibrillary acidic protein
|
1.089
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
1.088
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
1.088
|
|
THPO
|
thrombopoietin
|
1.087
|
|
ASPG
|
asparaginase
|
1.087
|
|
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha
|
1.087
|
|
SMAD3
|
SMAD family member 3
|
1.086
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
1.086
|
|
EDN1
|
endothelin 1
|
1.086
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
1.086
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
1.081
|
|
SAA1
|
serum amyloid A1
|
1.079
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.078
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.078
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.077
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
1.076
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
1.074
|
|
PYCARD
|
PYD and CARD domain containing
|
1.074
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.073
|
|
SYP
|
synaptophysin
|
1.072
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
1.072
|
|
PGR
|
progesterone receptor
|
1.071
|
|
IRF7
|
interferon regulatory factor 7
|
1.069
|
|
LOX
|
lysyl oxidase
|
1.069
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
1.069
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
1.068
|
|
CD2
|
CD2 molecule
|
1.067
|
|
NOX4
|
NADPH oxidase 4
|
1.067
|
|
CKB
|
creatine kinase, brain
|
1.066
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
1.063
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.063
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.063
|
|
ELN
|
elastin
|
1.063
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
1.062
|
|
WT1
|
Wilms tumor 1
|
1.061
|
|
CNTN2
|
contactin 2 (axonal)
|
1.057
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
1.057
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
1.057
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.055
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
1.055
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.055
|
|
CLDN7
|
claudin 7
|
1.055
|
|
CD163
|
CD163 molecule
|
1.053
|
|
GLB1
|
galactosidase, beta 1
|
1.053
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.052
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.052
|
|
MCOLN3
|
mucolipin 3
|
1.051
|
|
ORM1
|
orosomucoid 1
|
1.051
|
|
LEP
|
leptin
|
1.049
|
|
IL16
|
interleukin 16
|
1.048
|
|
CKM
|
creatine kinase, muscle
|
1.048
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
1.048
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
1.047
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
1.047
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
1.046
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
1.046
|
|
CLDN1
|
claudin 1
|
1.045
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.044
|
|
BCL2L1
|
BCL2-like 1
|
1.042
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
1.042
|
|
LY96
|
lymphocyte antigen 96
|
1.039
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
1.038
|
|
STX18
|
syntaxin 18
|
1.038
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.037
|
|
CEACAM21
|
carcinoembryonic antigen-related cell adhesion molecule 21
|
1.037
|
|
A2M
|
alpha-2-macroglobulin
|
1.036
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.035
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
1.035
|
|
ACO1
|
aconitase 1, soluble
|
1.035
|
|
KRT19
|
keratin 19, type I
|
1.032
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.031
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.03
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.028
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
1.028
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
1.027
|
|
TJP2
|
tight junction protein 2
|
1.026
|
|
CD9
|
CD9 molecule
|
1.025
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
1.025
|
|
MRC1
|
mannose receptor, C type 1
|
1.024
|
|
RRAD
|
Ras-related associated with diabetes
|
1.022
|
|
CDC42
|
cell division cycle 42
|
1.021
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.02
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
1.02
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
1.018
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.018
|
|
TRIM21
|
tripartite motif containing 21
|
1.017
|
|
LPAR4
|
lysophosphatidic acid receptor 4
|
1.017
|
|
SPAM1
|
sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)
|
1.017
|
|
KRT8
|
keratin 8, type II
|
1.017
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.016
|
|
VWF
|
von Willebrand factor
|
1.015
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
1.014
|
|
CLDN8
|
claudin 8
|
1.013
|
|
SAA2
|
serum amyloid A2
|
1.011
|
|
C5AR1
|
complement component 5a receptor 1
|
1.011
|
|
PANX1
|
pannexin 1
|
1.01
|
|
GPR55
|
G protein-coupled receptor 55
|
1.01
|
|
STX1A
|
syntaxin 1A (brain)
|
1.01
|
|
EGR1
|
early growth response 1
|
1.01
|
|
CTSG
|
cathepsin G
|
1.008
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.007
|
|
HTRA1
|
HtrA serine peptidase 1
|
1.006
|
|
BCR
|
breakpoint cluster region
|
1.004
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
1.002
|
|
UCN2
|
urocortin 2
|
1.0
|
|
FOXA1
|
forkhead box A1
|
1.0
|
|
CD27
|
CD27 molecule
|
1.0
|
